Sponsor Pipeline

AvenCell Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 1/2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07284433 Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With… Lymphoma Diffuse Large B-cell Recruiting
Not specified
NCT07474051 Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials B-cell Lymphoma Enrolling by Invitation
Disease Areas
Leukemia (2) Prostate Cancer (1) Acute Myeloid Leukemia (AML) (1) Chronic Lymphocytic Leukemia (CLL) (1)
Get alerts when AvenCell Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free